198 related articles for article (PubMed ID: 11935409)
1. Multiple sites of control of type-1 corticotropin releasing hormone receptor levels in the pituitary.
Nikodemova M; Diehl CR; Aguilera G
Arch Physiol Biochem; 2002 Apr; 110(1-2):123-8. PubMed ID: 11935409
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin releasing hormone receptors: two decades later.
Aguilera G; Nikodemova M; Wynn PC; Catt KJ
Peptides; 2004 Mar; 25(3):319-29. PubMed ID: 15134857
[TBL] [Abstract][Full Text] [Related]
3. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
4. Regulation of pituitary corticotropin releasing hormone receptors.
Aguilera G; Rabadan-Diehl C; Nikodemova M
Peptides; 2001 May; 22(5):769-74. PubMed ID: 11337090
[TBL] [Abstract][Full Text] [Related]
5. Regulation of messenger ribonucleic acid for corticotropin releasing hormone receptor in the pituitary during stress.
Rabadan-Diehl C; Kiss A; Camacho C; Aguilera G
Endocrinology; 1996 Sep; 137(9):3808-14. PubMed ID: 8756551
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats.
Grinevich V; Ma XM; Herman JP; Jezova D; Akmayev I; Aguilera G
J Neuroendocrinol; 2001 Aug; 13(8):711-23. PubMed ID: 11489088
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary corticotroph function after shunting of magnocellular vasopressin and oxytocin to the hypophyseal portal circulation.
Makara GB; Kiss A; Lolait SJ; Aguilera G
Endocrinology; 1996 Feb; 137(2):580-6. PubMed ID: 8593805
[TBL] [Abstract][Full Text] [Related]
8. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
Tizabi Y; Aguilera G
Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
[TBL] [Abstract][Full Text] [Related]
9. Acute stress-induced sensitization of the pituitary-adrenal response to heterotypic stressors: independence of glucocorticoid release and activation of CRH1 receptors.
Belda X; Daviu N; Nadal R; Armario A
Horm Behav; 2012 Sep; 62(4):515-24. PubMed ID: 22986335
[TBL] [Abstract][Full Text] [Related]
10. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin.
Hauger RL; Aguilera G
Endocrinology; 1993 Oct; 133(4):1708-14. PubMed ID: 8404613
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Scott LV; Dinan TG
Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
[TBL] [Abstract][Full Text] [Related]
12. Regulation of pituitary corticotropin releasing factor type-1 receptor mRNA binding proteins by modulation of the hypothalamic-pituitary-adrenal axis.
Wu Z; Ji H; Hassan A; Aguilera G; Sandberg K
J Neuroendocrinol; 2004 Mar; 16(3):214-20. PubMed ID: 15049852
[TBL] [Abstract][Full Text] [Related]
13. Regulation of pituitary ACTH secretion during chronic stress.
Aguilera G
Front Neuroendocrinol; 1994 Dec; 15(4):321-50. PubMed ID: 7895891
[TBL] [Abstract][Full Text] [Related]
14. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone.
Glavas MM; Ellis L; Yu WK; Weinberg J
Alcohol Clin Exp Res; 2007 Sep; 31(9):1598-610. PubMed ID: 17760789
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.
Willenberg HS; Bornstein SR; Hiroi N; Päth G; Goretzki PE; Scherbaum WA; Chrousos GP
Mol Psychiatry; 2000 Mar; 5(2):137-41. PubMed ID: 10822340
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone type I receptor messenger ribonucleic acid and protein levels in the ovine fetal pituitary: ontogeny and effect of chronic cortisol administration.
Green JL; Figueroa JP; Massman GA; Schwartz J; Rose JC
Endocrinology; 2000 Aug; 141(8):2870-6. PubMed ID: 10919274
[TBL] [Abstract][Full Text] [Related]
17. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity.
Deussing JM; Kühne C; Pütz B; Panhuysen M; Breu J; Stenzel-Poore MP; Holsboer F; Wurst W
J Cereb Blood Flow Metab; 2007 Aug; 27(8):1476-95. PubMed ID: 17293846
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic regulation of pituitary receptors for vasopressin and corticotropin releasing hormone.
Mason D; Hassan A; Chacko S; Thompson P
Arch Physiol Biochem; 2002 Apr; 110(1-2):74-89. PubMed ID: 11935403
[TBL] [Abstract][Full Text] [Related]
20. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes.
Neumann ID; Johnstone HA; Hatzinger M; Liebsch G; Shipston M; Russell JA; Landgraf R; Douglas AJ
J Physiol; 1998 Apr; 508 ( Pt 1)(Pt 1):289-300. PubMed ID: 9490853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
